| Health Care Equipment & Supplies Industry | Healthcare Sector | Mr. Steven Wedan CEO | ASX Exchange | AU0000054942 ISIN |
| United States Country | - Employees | - Last Dividend | 5 Feb 2024 Last Split | - IPO Date |
Imricor Medical Systems, Inc. is a pioneering company in the field of medical devices, specifically focusing on products that are compatible with magnetic resonance imaging (MRI) for cardiac catheter ablation procedures. The company has made significant strides since its inception in 2006 and is based out of Burnsville, Minnesota, USA. Their groundbreaking work revolves around the development, manufacture, sale, and distribution of innovative MRI-compatible tools that aim to improve the safety, efficiency, and outcomes of cardiac procedures. Additionally, Imricor is involved in contract research and licenses its advanced intellectual property for use in implantable devices, showcasing their versatility and commitment to advancing cardiac care.
Imricor Medical Systems, Inc. has developed a comprehensive range of products aimed at enhancing cardiac catheter ablation procedures with the unique advantage of MRI compatibility.
Beyond these innovative products, Imricor actively engages in contract research and intellectual property licensing, broadening the impact of their technological advancements into other areas of implantable medical devices. This multifaceted approach underlines their commitment to enhancing medical procedures and outcomes for patients globally.